RapidAI

Hiring activelyHealth & bio · Health SaaSAI-native

iSchemaView, Inc.

RapidAI delivers deep clinical AI on an enterprise platform, enhancing AI clinical assessment and transforming care across your service line programs.

rapidai.com · Menlo Park, CA

Source Form DCIK 0001988367as of 2026-10-04

Get alerts for raises like this Join the waitlist

Funding event

The round itself, as filed

Inferred stageSeries B

Sold of offered$25.0M of $25.0M

Filed2026-08-14

Days since filing51

Exemption claimed: Rule 506(b)
First-ever Form D: No
Date of first sale: 2026-02-17

Investors

No investors named: Form D does not list them

This round was amended. Amendment filing

Officers on the filing

Names and roles as filed; addresses are never stored

Karim KartiExecutive Officer · Director
David StoffelExecutive Officer
Gregory W. AlbersDirector
Roland BammerDirector
John DrewDirector
Erol Ali DervisDirector
Mark S. BrandinDirector
Brendan RenehanDirector

Health flags

Three flags, each with the raw inputs behind it · as of 2026-10-03

UndersubscribedNot flagged100% sold7.5 months since first sale

Prior raiseNot flaggedPrior raise not known—

AmendedFlaggedD/A on 2026-08-14amount offered changed from $25.0M

Open roles

On the employer's own careers page · checked 2026-09-24

Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.

Senior Product DesignerOCT 3United States · Product · Full Time · open 1 day
Lead Technical Support Engineer, DICOMSEP 24Bangalore, India · Professional Services · Full Time · open 10 days
Market Value and Health Outcomes DirectorSEP 24United States · Marketing · Full Time · open 10 days
Strategic Accounts Regional Vice PresidentSEP 24United States · Sales · Full Time · open 10 days
Account Executive- Northeast USASEP 24United States · Sales · Full Time · open 10 days

All filings

Every filing for this company, newest first, amendments included

2026-08-14$75.0M of $75.0MSeries C+inferredAmendmentsrc Form D
2026-08-14$25.0M of $25.0MSeries Binferredsrc Form D

Also raised in Health & bio

Same sector, 28 days to 2026-10-04

All Health & bio rounds

Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuiet CarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet

75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.

The week, written up